We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-2.82%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$583M
Cap. Flow
+$1.58B
Cap. Flow %
10.27%
Top 10 Hldgs %
12.37%
Holding
1,072
New
155
Increased
512
Reduced
204
Closed
181

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$88.9M
2
HIG icon
Hartford Financial Services
HIG
+$86.6M
3
EA
Electronic Arts
EA
+$85.8M
4
MDB icon
MongoDB
MDB
+$78.3M
5
ZS icon
Zscaler
ZS
+$70.6M

Sector Composition

Rank Sector Weight
1 Healthcare 29.86%
2 Technology 22.14%
3 Financials 10.01%
4 Consumer Discretionary 7.78%
5 Industrials 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TARS icon
501
Tarsus Pharmaceuticals
TARS
$2.96B
$5.14M 0.03%
100,149
-8,837
-8% -$437K
QSR icon
502
Restaurant Brands International
QSR
$25.3B
$5.13M 0.03%
76,998
-139,842
-64% -$9.02M
XPO icon
503
XPO
XPO
$23.2B
$5.12M 0.03%
+47,580
New +$6.05M
ETNB
504
DELISTED
89bio
ETNB
$5.09M 0.03%
700,754
+305,928
+77% +$2.67M
BNY
505
Bank of New York Mellon
BNY
$107B
$5.09M 0.03%
60,633
+16,969
+39% +$1.43M
ATYR
506
aTyr Pharma
ATYR
$50.1M
$5.08M 0.03%
1,681,595
-1,405
-0.1% -$5.12K
TNET icon
507
TriNet
TNET
$3.05B
$5.05M 0.03%
63,703
+17,625
+38% +$1.46M
CMPS
508
Compass Pathways
CMPS
$1.84B
$5.02M 0.03%
1,754,856
+1,292,927
+280% +$4.97M
INBX icon
509
Inhibrx
INBX
$1.28B
$5.01M 0.03%
+358,436
New +$4.87M
CPRX
510
DELISTED
Catalyst Pharmaceutical
CPRX
$5.01M 0.03%
206,478
-46,491
-18% -$1.05M
LUMN icon
511
Lumen
LUMN
$6.44B
$5.01M 0.03%
+1,277,137
New +$6.36M
MGY icon
512
Magnolia Oil & Gas
MGY
$5.83B
$5M 0.03%
+198,110
New +$4.8M
SLB icon
513
SLB Ltd
SLB
$76B
$4.95M 0.03%
118,351
+33,545
+40% +$1.37M
CRBG icon
514
Corebridge Financial
CRBG
$15.2B
$4.91M 0.03%
+155,474
New +$5.03M
ACAD icon
515
Acadia Pharmaceuticals
ACAD
$4.93B
$4.9M 0.03%
295,210
+268,445
+1,003% +$4.88M
ARM icon
516
Arm
ARM
$301B
$4.89M 0.03%
45,802
-167,436
-79% -$23.3M
ARVN icon
517
Arvinas
ARVN
$570M
$4.89M 0.03%
695,945
+3,212
+0.5% +$50.3K
DOMO icon
518
Domo
DOMO
$182M
$4.79M 0.03%
617,610
+21,926
+4% +$176K
PHIN icon
519
Phinia Inc
PHIN
$2.76B
$4.79M 0.03%
+112,864
New +$5.41M
APLS
520
DELISTED
Apellis Pharmaceuticals
APLS
$4.79M 0.03%
218,850
+29,373
+16% +$811K
AKBA icon
521
Akebia Therapeutics
AKBA
$249M
$4.77M 0.03%
+2,485,578
New +$5.07M
SBH icon
522
Sally Beauty Holdings
SBH
$1.53B
$4.75M 0.03%
525,495
+1,032
+0.2% +$10.2K
PHAT icon
523
Phathom Pharmaceuticals
PHAT
$679M
$4.71M 0.03%
751,692
-250,000
-25% -$1.52M
MBLY icon
524
Mobileye
MBLY
$2.18B
$4.71M 0.03%
+327,259
New +$5.35M
KMI icon
525
Kinder Morgan
KMI
$68.7B
$4.66M 0.03%
163,318
+47,244
+41% +$1.31M

Similar funds

Woodline Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Woodline Partners held 1,072 positions worth $15.4B, up 3.9% from $14.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Woodline Partners deployed $1.58B of net new capital in Q1 2025, opening 155 new positions and adding to 512 existing holdings. Its largest new stake was Electronic Arts: 635,574 shares worth $91.9M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Arthur J. Gallagher & Co, an estimated $174M trimmed.

  • Woodline Partners's largest Q1 2025 buy was Electronic Arts: 635,574 shares worth $91.9M.
  • Woodline Partners added most to Apple in Q1 2025, an estimated $88.9M increase.
  • Woodline Partners's biggest Q1 2025 reduction was Arthur J. Gallagher & Co, cutting an estimated $174M.
  • Woodline Partners fully exited TE Connectivity in Q1 2025, selling an estimated $127M.
  • Woodline Partners's ten largest holdings make up 12% of its $15.4B portfolio in Q1 2025.
  • Woodline Partners opened 155 new positions and closed 181 in Q1 2025.
  • Woodline Partners's portfolio value rose 3.9% quarter-over-quarter to $15.4B.

Based on Woodline Partners's 13F filing for Q1 2025, filed 15 May 2025.